We are live on ! Find out more
NA

NewEdge Advisors Portfolio holdings

AUM $27.7B
1-Year Est. Return 22.98%
This Fund
S&P 500
This Quarter Est. Return
+6.1%
1 Year Est. Return
+22.98%
3 Year Est. Return
+69.07%
5 Year Est. Return
+86.55%
10 Year Est. Return
+264.51%
AUM
$8.85B
AUM Growth
+$851M
Cap. Flow
+$412M
Cap. Flow %
4.65%
Top 10 Hldgs %
16.84%
Holding
3,702
New
289
Increased
1,323
Reduced
1,138
Closed
218

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$30.8M
2
UL icon
Unilever
UL
+$28.5M
3
CMCSA icon
Comcast
CMCSA
+$27.6M
4
ITW icon
Illinois Tool Works
ITW
+$27.1M
5
MDLZ icon
Mondelez International
MDLZ
+$26.8M

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$30.6M
2
ABT icon
Abbott
ABT
+$28.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$27.8M
4
DOV icon
Dover
DOV
+$27.1M
5
ULST icon
State Street Ultra Short Term Bond ETF
ULST
+$24.4M

Sector Composition

Rank Sector Weight
1 Technology 12.26%
2 Financials 5.78%
3 Healthcare 5.7%
4 Consumer Discretionary 4.46%
5 Industrials 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KODK icon
3401
Kodak
KODK
$809M
$143 ﹤0.01%
31
+21
+210% +$89
SNDL icon
3402
Sundial Growers
SNDL
$312M
$140 ﹤0.01%
102
– –
CMTL icon
3403
Comtech Telecommunications
CMTL
$49.7M
$137 ﹤0.01%
15
– –
PRTS icon
3404
CarParts.com
PRTS
$42.6M
$136 ﹤0.01%
3
– –
VIAV icon
3405
Viavi Solutions
VIAV
$7.95B
$136 ﹤0.01%
12
– –
CLOV icon
3406
Clover Health Investments
CLOV
$2.23B
$135 ﹤0.01%
150
– –
FWONA icon
3407
Liberty Media Series A
FWONA
$23.4B
$135 ﹤0.01%
+2
New +$126
INDB icon
3408
Independent Bank
INDB
$4.04B
$134 ﹤0.01%
+3
New +$156
NUS icon
3409
Nu Skin
NUS
$257M
$133 ﹤0.01%
4
– –
CNCR
3410
DELISTED
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
$129 ﹤0.01%
10
– –
KPRX icon
3411
Kiora Pharmaceuticals
KPRX
$11.4M
$129 ﹤0.01%
22
– –
TONX
3412
TON Strategy Co
TONX
$168M
$122 ﹤0.01%
1
– –
BBC icon
3413
Virtus Biotech Clinical Trials ETF
BBC
$46M
$120 ﹤0.01%
5
– –
SABS icon
3414
SAB Biotherapeutics
SABS
$266M
$120 ﹤0.01%
15
– –
CRDF icon
3415
Cardiff Oncology
CRDF
$63M
$119 ﹤0.01%
81
– –
LNN icon
3416
Lindsay Corp
LNN
$1.14B
$119 ﹤0.01%
+1
New +$124
APPH
3417
DELISTED
AppHarvest, Inc. Common Stock
APPH
$119 ﹤0.01%
321
– –
VJET
3418
DELISTED
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
$114 ﹤0.01%
65
– –
SABSW icon
3419
SAB Biotherapeutics Warrant
SABSW
$92.9K
$112 ﹤0.01%
1,072
– –
ZIMV
3420
DELISTED
ZimVie
ZIMV
$112 ﹤0.01%
10
-2
-17% -$19
DH icon
3421
Definitive Healthcare
DH
$77M
$110 ﹤0.01%
10
– –
ITRM
3422
DELISTED
Iterum Therapeutics
ITRM
$107 ﹤0.01%
100
– –
SCHR
3423
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
$102 ﹤0.01%
4
-490
-99% -$12.3K
OTLY
3424
Oatly Group
OTLY
$476M
$96 ﹤0.01%
2
– –
DMK
3425
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$92 ﹤0.01%
38
-1
-3% -$4
135 136
137
138 139

Similar funds

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
TWC
The Woodbridge Company Toronto, Ontario, Canada $27.8B AUM 46.78% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

NewEdge Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, NewEdge Advisors held 3,702 positions worth $8.85B, up 11% from $8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

NewEdge Advisors deployed $412M of net new capital in Q2 2023, opening 289 new positions and adding to 1,323 existing holdings. Its largest new stake was Franklin International Core Dividend Tilt Index ETF: 317,686 shares worth $9.29M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Accenture, an estimated $30.6M trimmed.

  • NewEdge Advisors's largest Q2 2023 buy was Franklin International Core Dividend Tilt Index ETF: 317,686 shares worth $9.29M.
  • NewEdge Advisors added most to AbbVie in Q2 2023, an estimated $30.8M increase.
  • NewEdge Advisors's biggest Q2 2023 reduction was Accenture, cutting an estimated $30.6M.
  • NewEdge Advisors fully exited Quadratic Deflation ETF in Q2 2023, selling an estimated $3.13M.
  • NewEdge Advisors's ten largest holdings make up 17% of its $8.85B portfolio in Q2 2023.
  • NewEdge Advisors opened 289 new positions and closed 218 in Q2 2023.
  • NewEdge Advisors's portfolio value rose 11% quarter-over-quarter to $8.85B.

Based on NewEdge Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.